Sam-A Pharm Co Ltd
KOSDAQ:009300
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Sam-A Pharm Co Ltd
Net Income (Common)
Sam-A Pharm Co Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Sam-A Pharm Co Ltd
KOSDAQ:009300
|
Net Income (Common)
₩13.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
31%
|
CAGR 10-Years
7%
|
|
|
Yuhan Corp
KRX:000100
|
Net Income (Common)
₩191.1B
|
CAGR 3-Years
27%
|
CAGR 5-Years
0%
|
CAGR 10-Years
4%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Net Income (Common)
₩267B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Net Income (Common)
₩169.6B
|
CAGR 3-Years
27%
|
CAGR 5-Years
70%
|
CAGR 10-Years
1%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Net Income (Common)
₩5.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-8%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Net Income (Common)
₩20.1B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
Sam-A Pharm Co Ltd
Glance View
Sam-A Pharm.Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Wonju, Gangwon-Do. The company went IPO on 2000-07-19. Co., Ltd is a Korea-based company engaged in the manufacture and sale of pharmaceuticals. The firm's products include remedies for respiratory, antibiotics, dermatitis treatments, dyspeptic agents, cold remedies, antifebriles, antiphlogistics, analgesics, antihistamines, and remedies for the circulatory, gastrointestinal, urinary systems, cardiovascular and other general pharmaceuticals. The company also provides children nutrition products under the brand name of NOMA.
See Also
What is Sam-A Pharm Co Ltd's Net Income (Common)?
Net Income (Common)
13.2B
KRW
Based on the financial report for Sep 30, 2025, Sam-A Pharm Co Ltd's Net Income (Common) amounts to 13.2B KRW.
What is Sam-A Pharm Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
7%
Over the last year, the Net Income (Common) growth was -42%. The average annual Net Income (Common) growth rates for Sam-A Pharm Co Ltd have been 6% over the past three years , 31% over the past five years , and 7% over the past ten years .
